Evidence Hub

Identification of potential drug candidates to treat gastritis and associated oxidative stress based on some novel 2-aryl-1 H -naphtho[2,3- d ]imidazole: synthesis, in vitro and in silico analysis

Amina Sultana, Aneela Wahab, Ghulam Fareed, Hamna Rafiq, Khalid Mohammed Khan, Mehreen Lateef, Nazia Fareed, Shafqat Hussain et al.

RSC Advances, 2024

2 citations

Abstract

, showed significant antioxidant activity. Molecular docking studies of the selected synthesized compounds 3, 4, 9, and 11 were also performed to determine their binding interaction with the jack bean urease. Through docking studies, it was revealed that all the compounds that showed good inhibitory potential against urease fit well within the protein's binding pocket. Furthermore, ADME analysis was carried out to explore the drug-likeness properties of the compounds. The findings of the present work revealed that compounds 4 and 11 could be better options to treat gastritis and associated oxidative stress.

How strong is the evidence?

Evidence Hub reads this as a simulation / modelling, done in cell cultures (in vitro) and computer models (in silico), not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free